16:48 EDT Cellectar Biosciences files to sell 34.49M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CLRB:
- Biotech Alert: Searches spiking for these stocks today
- Cellectar Biosciences Expands Global Intellectual Property Portfolio with Four Patent Grants
- Cellectar Biosciences secures four patents across key global regions
- Cellectar Biosciences Receives European Medicines Agency Priority Medicines (PRIME) Designation for Iopofosine for Waldenstrom’s Macroglobulinemia
- Cellectar Biosciences receives EMA PRIME designation for iopofosine